Form 4 for IBO IMPACT BIOMEDICAL INC.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-26 · accession 0001493152-24-048576 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-03 | 2024-11-26 | IBO | Heuszel Frank D | CEO, Dir | P - Purchase | $2.61 | +1,050 | 95.8K | +1% | +$2,742 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | P | A | 500 | $2.59 | 96,344 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-26 | P | A | 550 | $2.63 | 95,844 | D | — | — |